Appendiceal Mucinous Neoplasm clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
open to eligible people ages 18 years and up
This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritoneal (PMP) secondary to appendiceal mucinous neoplasms (AMNs).
at UC Irvine
Our lead scientists for Appendiceal Mucinous Neoplasm research studies include Oliver Eng.
Last updated: